Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ergoloid mesylates and ECT.

G S Sachs1, A J Gelenberg, B Bellinghausen

  • 1Department of Psychiatry, Harvard Medical School, Boston, MA.

The Journal of Clinical Psychiatry
|March 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of yoga training on the tinnitus induced distress.

Complementary therapies in clinical practice·2019
Same author

Age-related changes in the carcass composition and meat quality of fallow deer (DAMA DAMA L.).

Meat science·2018
Same author

Increased illness burden in women with comorbid bipolar and premenstrual dysphoric disorder: data from 1 099 women from STEP-BD study.

Acta psychiatrica Scandinavica·2017
Same author

Diffusion tensor imaging study of the fornix in first episode schizophrenia and in healthy controls.

Schizophrenia research·2014
Same author

Counterpoint : psychopharmacology supervision.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
Same author

Polypharmacy and bipolar disorder: what's personality got to do with it?

The international journal of neuropsychopharmacology·2013

Ergoloid mesylates showed a trend toward reducing amnesia after electroconvulsive therapy (ECT). This treatment also unexpectedly improved antidepressant response in patients undergoing ECT.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Amnesia is a common side effect of electroconvulsive therapy (ECT).
  • Exploring methods to mitigate ECT-associated cognitive impairment is crucial for patient care.

Purpose of the Study:

  • To investigate the potential of ergoloid mesylates in preventing ECT-induced amnesia.
  • To assess the impact of ergoloid mesylates on antidepressant response in ECT patients.

Main Methods:

  • A double-blind, placebo-controlled pilot study was conducted.
  • Patients received either ergoloid mesylates or a placebo before bilateral ECT.
  • Memory function was assessed using various memory tests.

Main Results:

Related Experiment Videos

  • Nonsignificant trends suggested improved memory performance in the ergoloid mesylates group.
  • Patients treated with ergoloid mesylates demonstrated a significantly enhanced antidepressant response.
  • The study highlights a potential dual benefit of ergoloid mesylates in ECT.

    • Conclusions:

    • Ergoloid mesylates may offer a protective effect against ECT-associated amnesia, though further research is needed.
    • Ergoloid mesylates significantly improved antidepressant outcomes in patients undergoing ECT.
    • This pilot study suggests a promising role for ergoloid mesylates in managing ECT side effects and efficacy.